The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment

  • Jeon, Young Hoon (Department of Anesthesiology and Pain Medicine, School of Dentistry, Kyungpook National University)
  • Received : 2015.05.16
  • Accepted : 2015.05.26
  • Published : 2015.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Herpes zoster (HZ) is a transient disease caused by the reactivation of latent varicella zoster virus (VZV) in spinal or cranial sensory ganglia. It is characterized by a painful rash in the affected dermatome. Postherpetic neuralgia (PHN) is the most troublesome side effect associated with HZ. However, PHN is often resistant to current analgesic treatments such as antidepressants, anticonvulsants, opioids, and topical agents including lidocaine patches and capsaicin cream and can persist for several years. The risk factors for reactivation of HZ include advanced age and compromised cell-mediated immunity (CMI). Early diagnosis and treatment with antiviral agents plus intervention treatments is believed to shorten the duration and severity of acute HZ and reduce the risk of PHN. Prophylactic vaccination against VZV can be the best option to prevent or reduce the incidence of HZ and PHN. This review focuses on the pathophysiology, clinical features, and management of HZ and PHN, as well as the efficacy of the HZ vaccine.

Keywords

References

  1. Gauthier A, Breuer J, Carrington D, Martin M, Remy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009; 137: 38-47. https://doi.org/10.1017/S0950268808000678
  2. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82: 1341-9. https://doi.org/10.4065/82.11.1341
  3. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med 2005; 352: 2266-7. https://doi.org/10.1056/NEJMp058091
  4. Thyregod HG, Rowbotham MC, Peters M, Possehn J, Berro M, Petersen KL. Natural history of pain following herpes zoster. Pain 2007; 128: 148-56. https://doi.org/10.1016/j.pain.2006.09.021
  5. Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology 2013; 81: 928-30. https://doi.org/10.1212/WNL.0b013e3182a3516e
  6. Panlilio LM, Christo PJ, Raja SN. Current management of postherpetic neuralgia. Neurologist 2002; 8: 339-50. https://doi.org/10.1097/00127893-200211000-00002
  7. Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis 1998; 5: 209-27. https://doi.org/10.1006/nbdi.1998.0204
  8. Baron R. Mechanisms of postherpetic neuralgia--we are hot on the scent. Pain 2008; 140: 395-6. https://doi.org/10.1016/j.pain.2008.10.018
  9. Chernev I, Dado D. Segmental zoster abdominal paresis (zoster pseudohernia): a review of the literature. PM R 2013; 5: 786-90. https://doi.org/10.1016/j.pmrj.2013.05.013
  10. Oaklander AL. The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain 2001; 92: 139-45. https://doi.org/10.1016/S0304-3959(00)00481-4
  11. Truini A, Galeotti F, Haanpaa M, Zucchi R, Albanesi A, Biasiotta A, et al. Pathophysiology of pain in postherpetic neuralgia: a clinical and neurophysiological study. Pain 2008; 140: 405-10. https://doi.org/10.1016/j.pain.2008.08.018
  12. Watson CP, Watt VR, Chipman M, Birkett N, Evans RJ. The prognosis with postherpetic neuralgia. Pain 1991; 46: 195-9. https://doi.org/10.1016/0304-3959(91)90076-A
  13. Garry EM, Delaney A, Anderson HA, Sirinathsinghji EC, Clapp RH, Martin WJ, et al. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 2005; 118: 97-111. https://doi.org/10.1016/j.pain.2005.08.003
  14. Premkumar LS. Targeting TRPV1 as an alternative approach to narcotic analgesics to treat chronic pain conditions. AAPS J 2010; 12: 361-70. https://doi.org/10.1208/s12248-010-9196-y
  15. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010; 9: 807-19. https://doi.org/10.1016/S1474-4422(10)70143-5
  16. Kidd BL, Urban LA. Mechanisms of inflammatory pain. Br J Anaesth 2001; 87: 3-11. https://doi.org/10.1093/bja/87.1.3
  17. Meller ST, Gebhart GF. A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain. Neuroscience 1992; 48: 501-24. https://doi.org/10.1016/0306-4522(92)90398-L
  18. Mannion RJ, Costigan M, Decosterd I, Amaya F, Ma QP, Holstege JC, et al. Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc Natl Acad Sci U S A 1999; 96: 9385-90. https://doi.org/10.1073/pnas.96.16.9385
  19. Dworkin RH, Gnann JW Jr, Oaklander AL, Raja SN, Schmader KE, Whitley RJ. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain 2008; 9: S37-44.
  20. Nahm FS, Kim SH, Kim HS, Shin JW, Yoo SH, Yoon MH, et al. Survey on the treatment of postherpetic neuralgia in Korea; multicenter study of 1,414 patients. Korean J Pain 2013; 26: 21-6. https://doi.org/10.3344/kjp.2013.26.1.21
  21. Arani RB, Soong SJ, Weiss HL, Wood MJ, Fiddian PA, Gnann JW, et al. Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med 2001; 20: 2429-39. https://doi.org/10.1002/sim.851
  22. Coen PG, Scott F, Leedham-Green M, Nia T, Jamil A, Johnson RW, et al. Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice? Eur J Pain 2006; 10: 695-700. https://doi.org/10.1016/j.ejpain.2005.11.002
  23. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62: 1545-51. https://doi.org/10.1212/01.WNL.0000123261.00004.29
  24. Volpi A, Gatti A, Pica F, Bellino S, Marsella LT, Sabato AF. Clinical and psychosocial correlates of post-herpetic neuralgia. J Med Virol 2008; 80: 1646-52. https://doi.org/10.1002/jmv.21254
  25. Espy MJ, Teo R, Ross TK, Svien KA, Wold AD, Uhl JR, et al. Diagnosis of varicella-zoster virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol 2000; 38: 3187-9.
  26. Shafran SD, Tyring SK, Ashton R, Decroix J, Forszpaniak C, Wade A, et al. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial. J Clin Virol 2004; 29: 248-53. https://doi.org/10.1016/S1386-6532(03)00164-1
  27. Shen MC, Lin HH, Lee SS, Chen YS, Chiang PC, Liu YC. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster. J Microbiol Immunol Infect 2004; 37: 75-81.
  28. Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc 2009; 84: 274-80. https://doi.org/10.4065/84.3.274
  29. De Clercq E. Selective anti-herpesvirus agents. Antivir Chem Chemother 2013; 23: 93-101. https://doi.org/10.3851/IMP2533
  30. Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996; 125: 376-83. https://doi.org/10.7326/0003-4819-125-5-199609010-00004
  31. Dworkin RH, Barbano RL, Tyring SK, Betts RF, McDermott MP, Pennella-Vaughan J, et al. A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain 2009; 142: 209-17. https://doi.org/10.1016/j.pain.2008.12.022
  32. van Wijck AJ, Opstelten W, Moons KG, van Essen GA, Stolker RJ, Kalkman CJ, et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet 2006; 367: 219-24. https://doi.org/10.1016/S0140-6736(06)68032-X
  33. Pasqualucci A, Pasqualucci V, Galla F, De Angelis V, Marzocchi V, Colussi R, et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand 2000; 44: 910-8. https://doi.org/10.1034/j.1399-6576.2000.440803.x
  34. Kumar V, Krone K, Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg Anesth Pain Med 2004; 29: 454-61.
  35. Baidya DK, Khanna P, Maitra S. Analgesic efficacy and safety of thoracic paravertebral and epidural analgesia for thoracic surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 2014; 18: 626-35. https://doi.org/10.1093/icvts/ivt551
  36. Makharita MY, Amr YM, El-Bayoumy Y. Single paravertebral injection for acute thoracic herpes zoster: a randomized controlled trial. Pain Pract 2015; 15: 229-35. https://doi.org/10.1111/papr.12179
  37. Ji G, Niu J, Shi Y, Hou L, Lu Y, Xiong L. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg 2009; 109: 1651-5. https://doi.org/10.1213/ANE.0b013e3181b79075
  38. Makharita MY, Amr YM, El-Bayoumy Y. Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia. Pain Physician 2012; 15: 467-74.
  39. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005; 2: e164. https://doi.org/10.1371/journal.pmed.0020164
  40. Vieweg WV, Wood MA. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes. Psychosomatics 2004; 45: 371-7. https://doi.org/10.1176/appi.psy.45.5.371
  41. Zin CS, Nissen LM, Smith MT, O'Callaghan JP, Moore BJ. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs 2008; 22: 417-42. https://doi.org/10.2165/00023210-200822050-00005
  42. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of post-herpetic neuralgia: a randomized controlled trial. JAMA 1998; 280: 1837-42. https://doi.org/10.1001/jama.280.21.1837
  43. Sabatowski R, Galvez R, Cherry DA, Jacquot F, Vincent E, Maisonobe P, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004; 109: 26-35. https://doi.org/10.1016/j.pain.2004.01.001
  44. Christo PJ, Hobelmann G, Maine DN. Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management. Drugs Aging 2007; 24: 1-19. https://doi.org/10.2165/00002512-200724010-00001
  45. Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003; 105: 71-8. https://doi.org/10.1016/S0304-3959(03)00160-X
  46. Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002; 59: 1015-21. https://doi.org/10.1212/WNL.59.7.1015
  47. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 2003; 104: 323-31. https://doi.org/10.1016/S0304-3959(03)00020-4
  48. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996; 65: 39-44. https://doi.org/10.1016/0304-3959(95)00146-8
  49. Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 2002; 18: 297-301. https://doi.org/10.1097/00002508-200209000-00004
  50. Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993; 15: 510-26.
  51. Kotani N, Kushikata T, Hashimoto H, Kimura F, Muraoka M, Yodono M, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000; 343: 1514-9. https://doi.org/10.1056/NEJM200011233432102
  52. Doi K, Nikai T, Sakura S, Saito Y. Intercostal nerve block with 5% tetracaine for chronic pain syndromes. J Clin Anesth 2002; 14: 39-41. https://doi.org/10.1016/S0952-8180(01)00351-8
  53. Jeon YH. Spinal cord stimulation in pain management: a review. Korean J Pain 2012; 25: 143-50. https://doi.org/10.3344/kjp.2012.25.3.143
  54. Harke H, Gretenkort P, Ladleif HU, Koester P, Rahman S. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth Analg 2002; 94: 694-700. https://doi.org/10.1097/00000539-200203000-00040
  55. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-84. https://doi.org/10.1056/NEJMoa051016

Cited by

  1. Risk Factor and Prevention of Postherpetic Neuralgia vol.28, pp.3, 2015, https://doi.org/10.3344/kjp.2015.28.3.167
  2. Korean Version of the painDETECT Questionnaire: A Study for Cultural Adaptation and Validation vol.17, pp.4, 2017, https://doi.org/10.1111/papr.12472
  3. Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study vol.29, pp.3, 2016, https://doi.org/10.1111/dth.12331
  4. Comparison of efficacy of continuous epidural block and pulsed radiofrequency to the dorsal root ganglion for management of pain persisting beyond the acute phase of herpes zoster vol.12, pp.8, 2017, https://doi.org/10.1371/journal.pone.0183559
  5. Herpes zoster – typical and atypical presentations vol.129, pp.6, 2017, https://doi.org/10.1080/00325481.2017.1335574
  6. Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial vol.18, pp.1, 2017, https://doi.org/10.1186/s13063-016-1729-y
  7. Psoas compartment block for treatment of motor weakness and pain following herpes zoster vol.30, pp.1, 2017, https://doi.org/10.3344/kjp.2017.30.1.62
  8. Chili pepper as a body weight-loss food vol.68, pp.4, 2017, https://doi.org/10.1080/09637486.2016.1258044
  9. Transdermal oxycodone patch for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled trial vol.7, pp.4, 2017, https://doi.org/10.2217/pmt-2016-0067
  10. Localized Vesicular Eruption vol.9, pp.1, 2017, https://doi.org/10.1097/JDN.0000000000000277
  11. Herpes Zoster vol.9, pp.2, 2017, https://doi.org/10.1097/JDN.0000000000000260
  12. Clinical efficacy of transforaminal epidural injection for management of zoster-associated pain: a retrospective analysis vol.47, pp.2, 2018, https://doi.org/10.1007/s00256-017-2795-2
  13. Modalities in managing postherpetic neuralgia vol.31, pp.4, 2018, https://doi.org/10.3344/kjp.2018.31.4.235
  14. Effectiveness of continuous epidural analgesia on acute herpes zoster and postherpetic neuralgia vol.97, pp.5, 2018, https://doi.org/10.1097/MD.0000000000009837
  15. Treatment of herpes zoster with ultrasound-guided superficial cervical plexus block vol.15, pp.4, 2015, https://doi.org/10.17245/jdapm.2015.15.4.247
  16. Efficacy of continuous epidural block in acute herpes zoster : Incidence and predictive factors of postherpetic neuralgia, a retrospective single-center study vol.95, pp.32, 2015, https://doi.org/10.1097/md.0000000000004577
  17. Comparative study between 2 different doses of pregabalin and lidocaine on pain following propofol injection : A double-blind, randomized clinical consort study vol.95, pp.51, 2016, https://doi.org/10.1097/md.0000000000005153
  18. Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain vol.8, pp.1, 2016, https://doi.org/10.3390/toxins8010018
  19. Association of serum Ninjurin2 levels with neurologic damage and postherpetic neuralgia occurrence: an observational cohort study in chinese herpeszoster patients vol.8, pp.42, 2015, https://doi.org/10.18632/oncotarget.17640
  20. The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia vol.11, pp.None, 2015, https://doi.org/10.2147/jpr.s154154
  21. Altered functional connectivity density in patients with herpes zoster and postherpetic neuralgia vol.11, pp.None, 2015, https://doi.org/10.2147/jpr.s154314
  22. The effect of ultrasound-guided percutaneous ozone injection around cervical dorsal root ganglion in zoster-associated pain: a retrospective study vol.11, pp.None, 2018, https://doi.org/10.2147/jpr.s163340
  23. Epidemiology, treatment and prevention of herpes zoster: A comprehensive review vol.84, pp.3, 2018, https://doi.org/10.4103/ijdvl.ijdvl_1021_16
  24. Disseminated herpes zoster involving bladder and severe inappropriate antidiuretic hormone in a immunocompetent elderly patient - A case report - vol.13, pp.1, 2015, https://doi.org/10.17085/apm.2018.13.1.98
  25. Herpes Zoster-induced Progressive Heart Block: A Case Report vol.10, pp.12, 2015, https://doi.org/10.7759/cureus.3674
  26. Ramsay Hunt syndrome vol.18, pp.6, 2018, https://doi.org/10.17245/jdapm.2018.18.6.333
  27. Risk Evaluation for Acute Kidney Injury Induced by the Concomitant Use of Valacyclovir, Analgesics, and Renin-Angiotensin System Inhibitors: The Detection of Signals of Drug-Drug Interactions vol.10, pp.None, 2015, https://doi.org/10.3389/fphar.2019.00874
  28. Characterizing the Structural Pattern Predicting Medication Response in Herpes Zoster Patients Using Multivoxel Pattern Analysis vol.13, pp.None, 2015, https://doi.org/10.3389/fnins.2019.00534
  29. Ultrasound Guided Continuous Sciatic Nerve Block for Acute Herpetic Neuralgia vol.2019, pp.None, 2015, https://doi.org/10.1155/2019/7948282
  30. Response to Transforaminal Epidural Block as a Useful Predictive Factor of Postherpetic Neuralgia vol.8, pp.3, 2019, https://doi.org/10.3390/jcm8030323
  31. The efficacy of selective nerve root block for the long-term outcome of postherpetic neuralgia vol.32, pp.3, 2015, https://doi.org/10.3344/kjp.2019.32.3.215
  32. Efficacy of valacyclovir and famciclovir in herpes zoster: A comparative study vol.52, pp.6, 2020, https://doi.org/10.4103/ijp.ijp_555_18
  33. Comparison of the Analgesic Effect of Ropivacaine with Fentanyl and Ropivacaine Alone in Continuous Epidural Infusion for Acute Herpes Zoster Management: A Retrospective Study vol.56, pp.1, 2015, https://doi.org/10.3390/medicina56010022
  34. Abnormal Intrinsic Brain Activity and Neuroimaging-Based fMRI Classification in Patients With Herpes Zoster and Postherpetic Neuralgia vol.11, pp.None, 2015, https://doi.org/10.3389/fneur.2020.532110
  35. Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia vol.33, pp.3, 2015, https://doi.org/10.3344/kjp.2020.33.3.201
  36. Disrupted default mode network dynamics in recuperative patients of herpes zoster pain vol.26, pp.12, 2015, https://doi.org/10.1111/cns.13433
  37. Effect of ultrasound-guided continuous erector spinae plane block on severe post-herpetic neuralgia in adolescent without skin rash vol.86, pp.12, 2015, https://doi.org/10.23736/s0375-9393.20.14881-8
  38. Pulsed Radiofrequency of the Trigeminal Ganglion for Treating Postherpetic Neuralgia of the Ophthalmic Branch vol.2021, pp.None, 2015, https://doi.org/10.1155/2021/6638392
  39. The effect of subcutaneous injection of methylprednisolone acetate and lidocaine for refractory postherpetic neuralgia: a prospective, observational study vol.4, pp.2, 2015, https://doi.org/10.1002/hsr2.271
  40. Unusual presentation of Ramsay‐Hunt Syndrome in kidney transplant patient vol.23, pp.4, 2015, https://doi.org/10.1111/tid.13658